M. Taki

发表

The Japanese Immune Tolerance Induction (J‐ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment

S. Ohga, T. Matsushita, K. Nogami, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan

J. Takamatsu, M. Taneichi, A. Shirahata, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Standard method for diagnosing dilatation of the renal pelvis and ureter discovered in the fetus, neonate or infant

H. Kakizaki, M. Kubota, M. Taki, 2004, International journal of urology : official journal of the Japanese Urological Association.

Protein C deficiency as the major cause of thrombophilias in childhood

T. Hara, D. Kang, S. Ohga, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Marked elevation of the thrombin generation potential following pulsed steroid therapy in a rabbit experiment

S. Tatsunami, M. Taki, Chiai Nagae, 2012 .

Neutralization effect of heparinase by thrombin generation test for the assessment of blood samples containing heparin

M. Taki, Chiai Nagae, S. Takayama, 2008 .

Pediatric thromboembolism: a national survey in Japan

A. Ishiguro, M. Taki, M. Shima, 2016, International Journal of Hematology.

The prevalence of neutralizing antibodies against adeno‐associated virus capsids is reduced in young Japanese individuals

T. Ohmori, S. Madoiwa, J. Mimuro, 2014, Journal of medical virology.

Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.

M. Taki, Y. Tsuda, K. Yamada, 1986, Thrombosis research.

Analysis of Anticoagulant Effect of Unfractionated Heparin by Using Thrombin Generation Assay in Vitro

S. Tatsunami, M. Taki, Chiai Nagae, 2015 .

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2016, The New England journal of medicine.

[Abnormal platelet adhesion to subendothelium and thrombus formation in glycogen storage disease, type I (author's transl)].

M. Taki, K. Yamada, M. Inagaki, 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Thrombosis in Children

M. Taki, Chiai Nagae, 2008 .

Statistics on HIV/AIDS among Japanese Hemophiliacs Infected with HIV-1

S. Tatsunami, A. Shirahata, M. Taki, 2008 .

Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV

S. Tatsunami, A. Shirahata, M. Taki, 2008, International journal of hematology.

Frequent Detection of Hepatitis C Virus US Strain in Japanese Hemophiliacs

T. Sugimura, N. Kato, K. Shimotohno, 1990, Japanese journal of cancer research : Gann.

Spontaneous platelet aggregation in Kawasaki disease using the particle counting method

M. Taki, Kenjiro Goto, K. Aso, 2003, Pediatrics international : official journal of the Japan Pediatric Society.

Three novel integrin beta3 subunit missense mutations (H280P, C560F, and G579S) in thrombasthenia, including one (H280P) prevalent in Japanese patients.

M. Murata, Y. Ikeda, M. Taki, 1998, Biochemical and biophysical research communications.

Factor VII Deficiency due to Compound Heterozygosity for Leu-48Pro Mutation and a Novel Pro260Leu Mutation

M. Taki, O. Takamiya, N. Kogiso, 2011, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Evaluation of the safety, pharmacokinetics, and efficacy of recombinant factor VIII fc fusion protein in Japanese subjects with severe haemophilia A: analysis from the A-LONG study

T. Matsushita, K. Nogami, M. Taki, 2016 .

Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis

Y. Toyama, J. Mimuro, J. Takamatsu, 2011 .

Structure and function of platelet glycoprotein Ib: study of the functional domain of glycoprotein Ib for von Willebrand factor binding using granulocyte elastase-like proteinase.

M. Taki, 1988, The Keio journal of medicine.

Inhibitory action of azelastine hydrochloride on the induction of mast cells from normal mouse splenocytes

K. Asano, M. Taki, Kaneo Yamada, 1997 .

[Platelet factor 4 and beta-thromboglobulin].

M. Taki, K. Yamada, 1987, Rinsho byori. The Japanese journal of clinical pathology.

A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A

M. Taki, Chiai Nagae, T. Ashikaga, 2016, International Journal of Hematology.

Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B

T. Matsushita, M. Taki, K. Fukutake, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

A 3-year consecutive survey on current status of acquired inhibitors against coagulation factors in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2008 .

Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan

A. Shirahata, M. Taki, 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2019, International Journal of Hematology.

Correction to: Inhibitor development, safety, and efficacy of Advate® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations

B. Konkle, Tetsuji Sato, T. Matsushita, 2017, International Journal of Hematology.

Japanese subject subpopulation analysis of B-LONG: a Phase 3 study of long-acting recombinant factor IX Fc fusion protein

T. Matsushita, M. Taki, M. Shima, 2015 .

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

A. Ishiguro, K. Yoneyama, K. Nogami, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Long-Term Safety and Efficacy of Nonacog Beta Pegol (N9-GP) Administered for at Least 5 Years in Previously Treated Children with Hemophilia B

E. Santagostino, M. Carcao, M. Taki, 2020, Thrombosis and Haemostasis.

Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2017, Blood advances.

Influence of granulocyte elastase-like proteinase (ELP) on platelet aggregation

M. Taki, T. Meguro, Kaneo Yamada, 1985 .

AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab – protocol for a multicentre, open-label, phase IV clinical study

A. Ishiguro, K. Nogami, M. Taki, 2022, BMJ Open.

Methodological issue of assay for inhibitors to factor VIII/IX

M. Taki, Satoshi Yamazaki, 2010 .

Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial

K. Nogami, M. Taki, K. Amano, 2022, BMJ Open.

Sub analysis of Japanese patients with hemophilia B in rIX-FP clinical trial

Koji Yamamoto, T. Matsushita, K. Nogami, 2017 .

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Tetsuji Sato, K. Yoneyama, T. Matsushita, 2014 .

Long‐term safety and efficacy of emicizumab for up to 5.8 years and patients’ perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A

T. Matsushita, K. Nogami, M. Taki, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Perioperative safety and hemostatic efficacy of Advate® in patients with hemophilia A in a postmarketing surveillance in Japan

J. Takamatsu, A. Shirahata, T. Matsushita, 2018, International Journal of Hematology.

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

S. Ohga, T. Matsushita, K. Nogami, 2015 .

A phase III clinical trial of a mixture agent of plasma‐derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors

Y. Ohashi, J. Takamatsu, H. Mugishima, 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

The International Immune Tolerance Induction Study and its follow-up study on Japanese hemophilia A patients with inhibitors

E. Ishii, Masao Kobayashi, A. Shirahata, 2015, International Journal of Hematology.

Clinical Study of Recombinant Factor VIIa (NN-007) in Hemophilia Patients with Inhibitors

J. Takamatsu, H. Saito, A. Shirahata, 1994 .

Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Report

M. Taki, K. Sakashita, T. Kurata, 2020, Acta Haematologica.

Every 2 Weeks or Every 4 Weeks Subcutaneous Injection of Emicizumab in Pediatric Patients with Severe Hemophilia A without Inhibitors: A Multi-Center, Open-Label Study in Japan (HOHOEMI Study)

A. Ishiguro, K. Yoneyama, K. Nogami, 2018, Blood.

Safety and effectiveness of albutrepenonacog alfa in Japanese patients with hemophilia B: Interim report of a post-marketing surveillance study

K. Nogami, M. Taki, M. Shima, 2022, Japanese Journal of Thrombosis and Hemostasis.

Clinical conditions and risk factors for inhibitor‐development in patients with haemophilia: A decade‐long prospective cohort study in Japan, J‐HIS2 (Japan Hemophilia Inhibitor Study 2)

J. Takamatsu, S. Ohga, Masao Kobayashi, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Plasma‐derived factor VIIa and factor X mixture agent (MC710) prophylaxis in haemophilia B patients with inhibitors

M. Migita, A. Shirahata, K. Nogami, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevalence of drug resistance-related mutations among HIV-1s in Japan.

S. Kashiwagi, W. Sugiura, J. Takamatsu, 1999, Japanese journal of infectious diseases.

Mode of action of FK-506 on protective immunity to Hymenolepis nana in mice.

K. Asano, M. Taki, K. Yamada, 1996, In vivo.

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

M. Hayakawa, S. Ishikawa, T. Ohmori, 2022, medRxiv.

A Nationwide Survey of Newly Diagnosed Childhood Idiopathic Thrombocytopenic Purpura in Japan

F. Bessho, M. Kubota, K. Fujisawa, 2009, Journal of pediatric hematology/oncology.

Consensus Guideline for Diagnosis and Treatment of Childhood Idiopathic Thrombocytopenic Purpura

F. Bessho, K. Fujisawa, A. Shirahata, 2006, International journal of hematology.

HLA-B polymorphism in Japanese HIV-1-infected long-term surviving hemophiliacs.

S. Oka, A. Kimura, M. Taki, 2005, Viral immunology.

HIV and HCV Coinfection in Hemophilliacs

S. Tatsunami, M. Taki, 2005 .

Cumulative Fraction of Patients with AIDS among Japanese Hemophiliacs Infected with HIV-1.

S. Tatsunami, J. Takamatsu, A. Shirahata, 1999 .

Successful treatment with vincristine of an infant with intractable Kasabach–Merritt syndrome

M. Taki, Y. Horikoshi, J. Mimaya, 2006, Pediatrics International.

Methodological characteristics of Factor VIII : C inhibitor assays and the availability of inactivation treatment

M. Taki, Chiai Nagae, S. Takayama, 2008 .

Estimation of the Number of Sustained Viral Responders by Interferon Therapy Using Random Numbers with a Logistic Model

Takahiko Ueno, S. Tatsunami, A. Shirahata, 2010 .

Prevalence of Hepatitis C Virus Infection in Coagulation Disorders in Japan

S. Tatsunami, A. Shirahata, M. Taki, 2003, International journal of hematology.

The Number of People in Japan with Coagulation Disorders: 2001 Update

Kaneo Yamada, Shinobu Tatsunami, S. Tatsunami, 2003, International journal of hematology.

Observed decline in the rate of death among Japanese hemophiliacs infected with HIV-1.

S. Tatsunami, J. Takamatsu, A. Shirahata, 2000, International journal of hematology.

[Causes of death (1983-1997) in patients infected with human immunodeficiency virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection].

S. Tatsunami, J. Takamatsu, A. Shirahata, 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Increasing Incidence of Critical Liver Disease among Causes of Death in Japanese Hemophiliacs with HIV-1

S. Tatsunami, A. Shirahata, M. Taki, 2004, Acta Haematologica.

[Transient myeloproliferative disorder (TMD) with transiently increased tetrasomy-21 cells in a phenotypically normal newborn].

S. Nakazawa, M. Taki, A. Watanabe, 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Spontaneous platelet aggregation in normal subject assessed by a laser light scattering method: An attempt at standardization

Yukio Ozaki, Hiroshi Sugihara, Satoshi Kurihara, 2008, Platelets.

Successful living‐related kidney transplantation in a boy with inherited dysfibrinogenemia

M. Hattori, F. Terasawa, M. Taki, 2013, Pediatric transplantation.

Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.

W. Sugiura, Z. Matsuda, M. Taki, 1999, Journal of human virology.

[Von Willebrand factor-cleaving protease activity in patients of collagen disease with antiphospholipid antibodies].

F. Miyake, M. Taki, Y. Fujimura, 2002, Rinsho byori. The Japanese journal of clinical pathology.

Japanese Nation-wide Survey on the Participation of HIV Infected Hemophiliacs in the Service for Health Care and in the Legal Proceedings for a Court Settlement of HIV Infection as a Result of Treatment with Blood Coagulation Factor Products

S. Tatsunami, A. Shirahata, M. Taki, 2000 .

Infection with hepatitis delta and human immunodeficiency viruses among hemophiliacs in Japan

M. Taki, F. Tsuda, Y. Miyakawa, 1988, Transfusion.

[Prospective matched control study concerning the treatment and quality of life of hemophiliacs with inhibitors].

H. Mohri, J. Takamatsu, A. Shirahata, 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Clinical and pathophysiological delineation of musculocontractural Ehlers—Danlos syndrome caused by dermatan sulfate epimerase deficiency (mcEDS‐DSE): A detailed and comprehensive glycobiological and pathological investigation in a novel patient

M. Taki, Takafumi Watanabe, T. Kosho, 2022, Human mutation.

Spectrum of F8 Genotype and Genetic Impact on Inhibitor Development in Patients with Hemophilia A from Multicenter Cohort Studies (J-HIS) in Japan

A. Shirahata, K. Nogami, M. Taki, 2020, Thrombosis and Haemostasis.

INF2 mutations in Charcot‐Marie‐Tooth disease complicated with focal segmental glomerulosclerosis

Kayoko Saito, H. Tsukaguchi, K. Hayasaka, 2013, Journal of the peripheral nervous system : JPNS.

A New Glucose-6-Phosphate Dehydrogenase Variant G6PD Sugao (826C→T) Exhibiting Chronic Hemolytic Anemia With Episodes of Hemolytic Crisis Immediately After Birth

M. Taki, H. Fujii, S. Miwa, 2001, International journal of hematology.

HIV type 1 subtypes of nonhemophiliac patients in Japan.

W. Sugiura, M. Taki, M. Honda, 1998, AIDS Research and Human Retroviruses.

Prevalence and persistence of a novel DNA TT virus (TTV) infection in Japanese haemophiliacs

M. Taki, S. Sugii, S. Matsuo, 1999, British journal of haematology.

Protein C deficiency as the major cause of thrombophilias in childhood

T. Hara, D. Kang, S. Ohga, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Virological characteristics of HCV infection in Japanese haemophiliacs

M. Taki, Kaneo Yamada, K. Yamada, 1997, Haemophilia : the official journal of the World Federation of Hemophilia.